University of Pittsburgh Hillman Cancer Center
University of Pittsburgh Hillman Cancer Center
Pittsburgh, Pennsylvania, United States3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| First In Human Study of CX-801 in Advanced Solid Tumors | Solid Tumor, Adult | Recruiting | Phase 1 | 2026-08-28 | NCT06462794 | |
| A Study of ZL-1310 in Subjects With Small Cell Lung Cancer | SCLC | Recruiting | Phase 1 | 2026-08-21 | NCT06179069 | |
| Study of Vorasidenib (AG-881) in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO) | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, epithelial neoplasm, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Phase 3 | 2025-04-03 | NCT04164901 |